TNK–Tissue Plasminogen Activator Compared With Front-Loaded Alteplase in Acute Myocardial Infarction
Open Access
- 22 December 1998
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 98 (25), 2805-2814
- https://doi.org/10.1161/01.cir.98.25.2805
Abstract
Background—Bolus thrombolytic therapy is a simplified means of administering thrombolysis that facilitates rapid time to treatment. TNK-tissue plasminogen activator (TNK-tPA) is a highly fibrin-spe...Keywords
This publication has 24 references indexed in Scilit:
- ACC/AHA guidelines for the management of patients with acute myocardial infarctionJournal of the American College of Cardiology, 1996
- Initial experience withhirudin andstreptokinase in acute myocardial infarction: Results of the thrombolysis in myocardial infarction (TIMI) 6 trialThe American Journal of Cardiology, 1995
- Time as an adjunctive agent to thrombolytic therapyJournal of Thrombosis and Thrombolysis, 1994
- Individual risk assessment for intracranial haemorrhage during thrombolytic therapyThe Lancet, 1993
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- “Plasminogen steal” and clot lysisJournal of the American College of Cardiology, 1992
- Pharmacokinetics and fibrin specificity of alteplase during accelerated infusions in acute myocardial infarctionJournal of the American College of Cardiology, 1992
- Comparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial InfarctionNew England Journal of Medicine, 1989
- Thrombolysis in myocardial infarction (TIMI): Comparative studies of coronary reperfusion and systemic fibrinogenolysis with two forms of recombinant tissue-type plasminogen activatorJournal of the American College of Cardiology, 1987
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985